Alzheimer’s drugs eyed as next big obesity-like opportunity
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Benzinga (Video) on MSN11h
Cognition Therapeutics Is Targeting A Critical Form Of Dementia
Lisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...
verywellhealth12h
What Happens to Your Brain When You Take These 16 Supplements?
While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...
What Type of Doctor Treats Dementia and Cognitive Decline?
If you or a loved one is showing potential signs of age-related cognitive decline or dementia, you may want to seek help but not know the right type of health care provider to choose. That' ...
New dementia tool predicts when symptoms will start: ‘Would you want to know?’
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
China Medical System （00867）Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer’s Type
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Hosted on MSN2d
Breakthrough drugs herald ‘new era’ in battle against dementia, experts predict
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
Undark3d
Why Alzheimer’s Scientists Are Re-thinking the Amyloid Hypothesis
Recent studies implicate the immune system and a herpes virus as potential contributors to development of the disease.